AP NEWS

China $4.33 Bn Genetic Testing Market to 2023 by Test Type, Disease, Technology, Service Provider & Testing Sample - ResearchAndMarkets.com

January 10, 2019

DUBLIN--(BUSINESS WIRE)--Jan 10, 2019--The “China Genetic Testing Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023” report has been added to ResearchAndMarkets.com’s offering.

China Genetic Testing Market reached a value of US$ 1.43 Billion in 2017. Looking forward, the market is expected to reach a value of US$ 4.33 Billion by 2023, exhibiting a CAGR of 18.9% during 2018-2023.

The results obtained from a genetic test can confirm or rule out a suspected genetic disorder or help identify a person’s chance of developing or passing on a genetic disorder. Genetic testing is becoming popular in China. It may benefit many different interest groups, such as individuals and families with a history of genetic disorder, pregnant women, employers, and health or life insurance. This market is currently driven by a number of factors such as rising awareness regarding the benefits of genetic testing, availability of direct to consumer tests and increasing incidences of genetic disorders.

Over the past few years, there has been a significant rise in the awareness levels regarding the benefits of genetic testing in China. Genetic testing provides various technologies that help in the early detection of various chronic diseases and ensures its treatment and prevention. Moreover, a rise in the availability of Direct to consumer tests (DTC) which has increased the convenience and accessibility of such tests is also creating a positive impact in the growth of the market.

Other major factors that are expected to drive this market include growing middle class, aging population, and expanding healthcare system.

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 China Genetic Testing Market

6 Market Breakup by Test Type

7 Market Breakup by Disease

8 Market Breakup by Technology

9 Market Breakup by Service Provider

10 Market Breakup by Testing Sample

11 Competitive Landscape

12 Key Player Profiles

BGI Shenzhen Huada Gene Technology Co Ltd. Berry Genomics Co. ltd. Daan Gene Co. Ltd WuXi NextCODE Annoroad Gene Technology Co. Ltd. WuXi PharmaTech

For more information about this report visit https://www.researchandmarkets.com/research/w7rtqj/china_4_33_bn?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190110005388/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Genomics

KEYWORD: ASIA PACIFIC CHINA

INDUSTRY KEYWORD: HEALTH GENETICS

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/10/2019 09:03 AM/DISC: 01/10/2019 09:03 AM

http://www.businesswire.com/news/home/20190110005388/en

AP RADIO
Update hourly